Read by QxMD icon Read

Isolated node ovarian cancer recurrence

Floriana Mascilini, Lorena Quagliozzi, Francesca Moro, Maria Cristina Moruzzi, Valerio Gallotta, Salvatore Gueli Alletti, Giovanni Scambia, Antonia Carla Testa, Anna Fagotti
STUDY OBJECTIVE: To describe the potential role of intraoperative ultrasound (IOUS) in the detection and localization of recurrent disease in gynecologic cancer patients during minimally invasive surgery (MIS). DESIGN: A prospective cohort study (Canadian Task Force classification II-1). SETTING: A university hospital. PATIENTS: Fifty-one gynecologic cancer patients with isolated recurrent disease. INTERVENTIONS: IOUS during secondary cytoreductive surgery (SCS) by MIS...
January 8, 2018: Journal of Minimally Invasive Gynecology
Kazuyoshi Kato, Hidetaka Nomura, Minoru Nagashima, Nobuhiro Takeshima
OBJECTIVE: We report the details of a cytoreduction technique for pelvic lymph node recurrence with involvement of the external iliac vein (EIV) requiring a partial resection and reconstruction of the EIV. METHODS: A 51-year-old woman presented with ovarian cancer and isolated nodal recurrence located on the right side of the pelvis. As the tumor had infiltrated the EIV wall, we performed the EIV excision and reconstruction using an autogenous graft. RESULTS: EIV reconstruction was achieved using a right ovarian vein patch...
December 2016: Gynecologic Oncology
Nejat Ozgul, Derman Basaran, Gokhan Boyraz, Mehmet Coskun Salman
No abstract text is available yet for this article.
August 2015: Gynecologic Oncology
Kazuyoshi Kato, Tomoka Usami, Nobuhiro Takeshima
OBJECTIVE: To present a case that involved para-aortic lymphadenectomy in the aortocaval and retrocaval region involving the division of the left renal vein (LRV). METHODS: A 36-year-old woman presented with ovarian cancer and isolated nodal recurrence located in the aortocaval and retrocaval region above and below the renal vein. Cytoreduction of para-aortic lymph nodes involving the division of the LRV was performed. RESULTS AND CONCLUSION: Division of the LRV facilitates the separation of the lymph nodes from the renal artery or inferior vena cava under direct vision...
April 2015: Gynecologic Oncology
Valerio Gallotta, Francesco Fanfani, Anna Fagotti, Vito Chiantera, Francesco Legge, Salvatore Gueli Alletti, Camilla Nero, Alessandro Pasquale Margariti, Valerio Papa, Sergio Alfieri, Francesca Ciccarone, Giovanni Scambia, Gabriella Ferrandina
BACKGROUND: The aim of this retrospective study was to investigate the incidence of mesenteric lymph node (MLN) involvement, and its prognostic role in advanced ovarian cancer (OC). METHODS: OC patients undergoing rectosigmoid resection during primary debulking surgery or interval debulking surgery were recorded. Progression-free survival (PFS) and overall survival were calculated from the date of diagnosis to the date of relapse/progression, death of disease, or the date of last follow-up...
July 2014: Annals of Surgical Oncology
Xiao-Jun Yang, Fei-Yun Zheng, Yun-Sheng Xu, Rong-Ying Ou
Isolated superficial inguinal metastases without any extended intra-abdominal spread is a rare event in patients with ovarian carcinoma. Here we report an isolated superficial inguinal metastasis in a patient with primary ovarian cancer. A 54-year-old Chinese patient with primary ovarian cancer, had an isolated painless enlarged right groin swelling (3×2cm) as the only manifestation, preoperative pathology confirmed metastatic adenocarcinoma. Gynecologic examination, transvaginal ultrasonography of the abdominopelvic cavity revealed a 5-cm mixed, right adnexal mass...
February 10, 2014: Journal of Ovarian Research
A Ferrero, A Ditto, G Giorda, A Gadducci, S Greggi, A Daniele, L Fuso, E Panuccio, C Scaffa, F Raspagliesi, P Sismondi, N Biglia
INTRODUCTION: Chemotherapy is the standard treatment of recurrent epithelial ovarian cancer (EOC), but its use in nodal relapses is still debated. On the other hand, the role of secondary cytoreductive surgery (SCS) remains controversial. Aim of this study is to evaluate feasibility and outcomes of SCS for the specific setting of recurrent ovarian cancer, exclusively relapsing in lymph nodes. PATIENTS AND METHODS: We conducted a retrospective analysis in five Italian Institutions (University of Torino, INT of Milano, CRO of Aviano, University of Pisa and INT of Napoli) from 2000 to 2012...
July 2014: European Journal of Surgical Oncology
Stephanie L Wethington, Kay J Park, Robert A Soslow, Noah D Kauff, Carol L Brown, Fanny Dao, Ebunoluwa Otegbeye, Yukio Sonoda, Nadeem R Abu-Rustum, Richard R Barakat, Douglas A Levine, Ginger J Gardner
OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) is recommended for women with BRCA mutation due to increased risk of pelvic serous carcinoma. Serous tubal intraepithelial carcinoma (STIC) is a pathologic finding of unknown clinical significance. This study evaluates the clinical outcome of patients with isolated STIC. MATERIALS/METHODS: We retrospectively reviewed the medical records of consecutive patients with a germline BRCA1/2 mutation or a high-risk personal or family history of ovarian cancer who underwent RRSO between January 2006 and June 2011...
November 2013: International Journal of Gynecological Cancer
Chien-Wen Chen, Pao-Ling Torng, Chi-Ling Chen, Chi-An Chen
BACKGROUND: Neck lymph node metastasis (NLNM) in epithelial ovarian cancer (EOC) is rare and treated as advanced stage cancer. However, ovarian cancer with lymphatic metastasis may manifest a different clinical course from peritoneal carcinomatosis. METHODS: The authors retrospectively assessed 20 patients with EOC and pathologically diagnosed as NLNM between January 2001 and December 2010. The patients were divided into two groups according to the time of NLNM identification...
October 3, 2013: World Journal of Surgical Oncology
Kazuyoshi Kato, Kohei Omatsu, Nobuhiro Takeshima
OBJECTIVE: We describe our early experience with a suprarenal and retrorenal para-aortic lymphadenectomy involving the mobilization of the left kidney. METHODS: Three patients with isolated nodal recurrence located in the region above and behind the renal vein underwent the removal of these metastatic lymph nodes using a left renal mobilization procedure. RESULTS AND CONCLUSION: The enlarged suprarenal and retrorenal lymph nodes were safely and effectively removed in all 3 patients...
July 2013: Gynecologic Oncology
Hua Tu, He Huang, Qi-dan Huang, Zheng Li, Yan-ling Feng, Ji-hong Liu
OBJECTIVE: To evaluate the management and survival of lymph node region recurrence of epithelial ovarian cancer (EOC), and discuss its suitable therapeutic strategy. METHODS: Thirty-eight patients with the recurrence of lymph node region were extracted from 1945 patients who were diagnosed EOC and treated in Sun Yat-sen University Cancer Center from January 1995 to December 2008. The clinical characteristics, therapy methods and survival of them were retrospectively analyzed...
December 2012: Zhonghua Fu Chan Ke za Zhi
Charles Honoré, Diane Goéré, Amine Souadka, Frédéric Dumont, Dominique Elias
BACKGROUND: In colorectal cancer, complete cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy achieves encouraging results in early peritoneal carcinomatosis (PC), but this early detection can only be accurately accomplished during a systematic second-look surgery. This costly and invasive approach can only be proposed to selected patients. The objective of this study was to identify risk factors predictive of developing PC after curative surgery for colorectal cancer...
January 2013: Annals of Surgical Oncology
Clarisse Eveno, Diane Goéré, Peggy Dartigues, Charles Honoré, Frédéric Dumont, Dimitri Tzanis, Léonor Benhaim, David Malka, Dominique Elias
PURPOSE: To analyze the patterns of recurrence and the prognostic impact of ovarian metastases (OM) in a population of women with colorectal peritoneal carcinomatosis (CRPC) treated with curative intent. METHODS: Data from all consecutive women with CRPC who underwent curatively intended complete cytoreductive surgery (CRS) plus intraperitoneal chemotherapy at our institution were retrieved from a prospective database. A bilateral oophorectomy or a complementary unilateral oophorectomy was systematically performed during CRS...
February 2013: Annals of Surgical Oncology
Tomohito Tanaka, Masahide Ohmichi
INTRODUCTION: The majority of ovarian cancer recurrences are in the abdomen. However, some cases relapse as isolated lymph node metastases, mostly in pelvic or para-aortic nodes. Peripheral isolated lymph node metastasis is rare. CASE PRESENTATION: A 69-year-old Japanese woman had recurrent ovarian cancer presenting with isolated right supraclavicular lymph node metastasis. After surgical resection and combination chemotherapy with carboplatin and paclitaxel, her right supraclavicular lymph node completely regressed...
2012: Journal of Medical Case Reports
Alessandra Bernardi, Paolo Castellucci, Andrea Angelo Martoni
Internal mammary lymph nodes as solitary site of recurrent ovarian cancer have not been previously described. In this case report, 3 cases of late and very late isolated recurrence in internal mammary lymph nodes are presented. (18)F-FDG-PET/CT allowed the diagnosis which was suspected by the increase of the serum CA-125 level in 2 out of 3 cases. Local treatment, consisting of surgery (in 2 patients) and radiation therapy (in 1 patient), permitted an optimal long-term disease control.
January 2011: Case Reports in Oncology
Olusola O Faluyi, Charlie Gourley, John F Smyth, Dana Faratian, Alistair R Williams, Tzyvia Rye, Ron Rye, Moira Stewart, Melanie J Mackean
BACKGROUND: The pathogenesis of brain metastasis as a relatively rare complication of epithelial ovarian cancer is poorly understood. Some observations suggest that brain metastases from ovarian cancer are becoming more common and that ovarian cancers, which metastasize to the brain, may have a different biological pattern. METHODS: Data were extracted from the Edinburgh Ovarian Cancer Database on a cohort of patients managed at the Edinburgh Cancer Centre (UK) between 1998 and 2004...
December 2010: International Journal of Gynecological Cancer
René Adam, Robbert J de Haas, Dennis A Wicherts, Eric Vibert, Chadi Salloum, Daniel Azoulay, Denis Castaing
OBJECTIVE: To evaluate the impact of the location of extrahepatic disease (EHD) on survival and to determine patient outcome in a consecutive series of patients with both intrahepatic and extrahepatic colorectal metastases treated by an oncosurgical approach, combining repeat surgery and chemotherapy. BACKGROUND: Although recognized as poor prognostic factor, concomitant EHD is no more considered an absolute contraindication to surgery in patients with colorectal liver metastases (CLM)...
February 2011: Annals of Surgery
A Martínez, D Querleu, E Leblanc, F Narducci, G Ferron
OBJECTIVE: To estimate the incidence of clinically detected port-site metastases (PSM) in patients with endometrial and cervical cancer treated at two gynecologic oncology services with extensive experience. METHODS: All eligible uterine cancer patients laparoscopically staged at Centre Oscar Lambret in Lille and Institut Claudius Regaud in Toulouse, France, were reviewed. MEDLINE database was searched to identify articles on PSM after laparoscopic procedures for cervical and endometrial cancer...
August 1, 2010: Gynecologic Oncology
Jonathan S Berek
INTRODUCTION: Ovarian cancer spreads via the retroperitoneal lymphatics, and these lymph nodes frequently contain metastasis. A subset of patients whose disease was classified as stage IIIC has retroperitoneal lymph node metastases in the pelvic and/or para-aortic lymph nodes without intraperitoneal carcinomatosis and was upstaged from stage I to IIIB diseases based on these findings. Patients undergoing cytoreductive surgery for advanced-stage ovarian cancer undergo concomitant retroperitoneal lymphadenectomy in an effort to improve their survival...
December 2009: International Journal of Gynecological Cancer
Angiolo Gadducci, Stefania Cosio, Paolo Zola, Benedetta Sostegni, Anna Maria Ferrero, Giancarlo Teti, Renza Cristofani, Enrico Sartori
OBJECTIVES: To assess the clinical outcome of epithelial ovarian cancer patients who developed an apparently isolated lymph node recurrence after primary therapy. METHODS: The authors retrospectively assessed 69 patients with epithelial ovarian cancer who were clinically or pathologically free of disease after primary therapy and who subsequently developed an apparently isolated lymph node recurrence. The median follow-up of survivors was 74.5 months. RESULTS: Median age was 58 years, FIGO stage was III-IV in 52 (75%) patients, residual disease after primary surgery was >1 cm in 36 (52%), first-line chemotherapy consisted of paclitaxel-/platinum-based chemotherapy in 44 (64%), time to recurrence was >12 months in 43 (62%), recurrence was pelvic and/or para-aortic in 41 (59%), and treatment at recurrence consisted of chemotherapy alone in 44 (64%), surgery plus chemotherapy in 22 (32%), surgery alone in one patient, surgery plus irradiation in one, and irradiation alone in one patient...
March 2010: Gynecologic Oncology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"